Healthcare Realty Trust appointed Daniel Gabbay as CFO, effective January 12, 2026, succeeding Austen Helfrich.
Quiver AI Summary
Healthcare Realty Trust Incorporated announced the appointment of Daniel Gabbay as Executive Vice President and Chief Financial Officer, effective January 12, 2026. Gabbay, who has a strong background in real estate investment banking and has worked at RBC Capital Markets and Barclays, brings nearly 20 years of experience in the sector. He has advised major healthcare REIT transactions and holds an MBA from Harvard and degrees from Wharton and the University of Pennsylvania. Peter Scott, President and CEO of Healthcare Realty, expressed enthusiasm about Gabbay's appointment, highlighting his relevant expertise. The press release also noted that Austen Helfrich, the outgoing CFO, will leave the company to pursue other opportunities. There will be no changes to the company's previously issued 2025 Normalized FFO guidance.
Potential Positives
- Appointment of Daniel Gabbay as Executive Vice President and Chief Financial Officer enhances leadership with a strong background in healthcare REITs and investment banking.
- Mr. Gabbay's previous experience includes advising on significant mergers, which may provide strategic advantages for Healthcare Realty in future transactions.
- Company's leadership expresses confidence in Gabbay's ability to contribute to the ongoing strategic vision and capitalize on favorable industry trends.
- No change to previously issued 2025 Normalized FFO guidance indicates stability and confidence in financial performance despite leadership transition.
Potential Negatives
- The departure of Austen Helfrich, the previous CFO, may indicate potential instability or transition challenges within the financial leadership of the company.
- The need to appoint a new CFO could signal underlying issues that necessitate a change in leadership during a critical financial period.
- The press release hints at possible risks and uncertainties regarding the company's future financial performance, as outlined in the forward-looking statements section.
FAQ
Who is the new CFO of Healthcare Realty?
Daniel Gabbay has been appointed as the new Executive Vice President and Chief Financial Officer of Healthcare Realty Trust.
When will Daniel Gabbay assume his role?
Mr. Gabbay will officially take on his role as CFO on January 12, 2026.
What experience does Daniel Gabbay bring to Healthcare Realty?
He has extensive experience in investment banking with a focus on the healthcare REIT sector and has advised on major mergers.
Who did Daniel Gabbay replace as CFO?
He replaces Austen Helfrich, who served as CFO since October 2024 and is leaving to pursue new business opportunities.
Is there any change to the 2025 FFO guidance after this appointment?
No, there is no change to Healthcare Realty's previously issued 2025 Normalized FFO guidance.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$HR Insider Trading Activity
$HR insiders have traded $HR stock on the open market 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $HR stock by insiders over the last 6 months:
- JULIE F. WILSON (EVP, Chief Admin. Officer) sold 15,000 shares for an estimated $270,000
- THOMAS N BOHJALIAN purchased 10,000 shares for an estimated $164,600
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$HR Revenue
$HR had revenues of $297.8M in Q3 2025. This is a decrease of -5.6% from the same period in the prior year.
You can track HR financials on Quiver Quantitative's HR stock page.
$HR Hedge Fund Activity
We have seen 186 institutional investors add shares of $HR stock to their portfolio, and 189 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PRICE T ROWE ASSOCIATES INC /MD/ added 14,388,480 shares (+1534.7%) to their portfolio in Q3 2025, for an estimated $259,424,294
- RUSH ISLAND MANAGEMENT, LP removed 6,456,801 shares (-45.3%) from their portfolio in Q3 2025, for an estimated $116,416,122
- RESOLUTION CAPITAL LTD added 6,402,102 shares (+inf%) to their portfolio in Q3 2025, for an estimated $115,429,899
- INVESCO LTD. added 5,393,651 shares (+233.8%) to their portfolio in Q3 2025, for an estimated $97,247,527
- THRIVENT FINANCIAL FOR LUTHERANS added 4,865,078 shares (+3181.0%) to their portfolio in Q3 2025, for an estimated $87,717,356
- STARBOARD VALUE LP removed 4,800,636 shares (-24.9%) from their portfolio in Q3 2025, for an estimated $86,555,467
- DEUTSCHE BANK AG\ added 4,414,167 shares (+440.9%) to their portfolio in Q3 2025, for an estimated $79,587,431
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$HR Analyst Ratings
Wall Street analysts have issued reports on $HR in the last several months. We have seen 2 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Cantor Fitzgerald issued a "Overweight" rating on 10/01/2025
- BTIG issued a "Buy" rating on 09/29/2025
- Raymond James issued a "Underperform" rating on 09/15/2025
To track analyst ratings and price targets for $HR, check out Quiver Quantitative's $HR forecast page.
$HR Price Targets
Multiple analysts have issued price targets for $HR recently. We have seen 6 analysts offer price targets for $HR in the last 6 months, with a median target of $19.5.
Here are some recent targets:
- John Kilichowski from Wells Fargo set a target price of $19.0 on 11/25/2025
- Nick Joseph from Citigroup set a target price of $19.0 on 11/12/2025
- Michael Carroll from RBC Capital set a target price of $19.0 on 10/08/2025
- Richard Anderson from Cantor Fitzgerald set a target price of $23.0 on 10/01/2025
- Michael Gorman from BTIG set a target price of $20.0 on 09/29/2025
- Nicholas Yulico from Scotiabank set a target price of $20.0 on 09/05/2025
Full Release
NASHVILLE, Tenn., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Healthcare Realty Trust Incorporated (NYSE:HR) (“Healthcare Realty” or the “Company”) today announced the appointment of Daniel Gabbay as Executive Vice President and Chief Financial Officer (“CFO”). He will be based at the Company’s Nashville headquarters and assume his new role on January 12, 2026.
Since 2024, Mr. Gabbay served as a Managing Director in the Real Estate Investment Banking Group of RBC Capital Markets (“RBC”), with primary coverage responsibility of the healthcare REIT sector. Prior to joining RBC, he served as a Managing Director in the Real Estate Investment Banking Group at Barclays. During his nearly 20-year career in investment banking, Dan has provided advisory and capital markets services to clients across the real estate industry. Most recently, he advised Sonida Senior Living, Inc. on its announced $3 billion combination with CNL Healthcare Properties, Inc. and prior to that advised Healthpeak Properties, Inc. on its $5 billion strategic merger with Physicians Realty Trust. Mr. Gabbay holds a Masters in Business Administration from Harvard Business School, a Bachelor of Science from The Wharton School and a Bachelor of Arts from the University of Pennsylvania. He began his career at Lehman Brothers in 2001.
“I am incredibly excited to welcome Dan to Healthcare Realty,” said Peter Scott, President and CEO. “I have known and worked closely with Dan for over two decades, and he has a proven track record of leadership and success throughout his career. Dan brings an exceptional blend of strategic insight, analytical rigor, and capital markets expertise, not to mention deep experience in our sector. I look forward to working closely with him as part of our senior leadership team going forward.”
Commenting on his appointment, Mr. Gabbay said, “I am honored by the opportunity to serve as Healthcare Realty’s CFO and excited to get started. I look forward to working with the talented team at Healthcare Realty as we continue to execute upon the strategic vision which Pete and the Board laid out last year. As the leading pure-play outpatient medical REIT, Healthcare Realty has the best-in-class platform to capitalize on favorable industry trends.”
In addition, the Company has announced that Austen Helfrich, who has served as CFO since October 2024, will be departing to pursue new business opportunities.
“Since joining the Company in 2019, Austen made significant contributions across the organization. I am grateful for his partnership and strong financial leadership during a critical time for Healthcare Realty. On behalf of the Company and our Board of Directors, I sincerely thank Austen for his service and wish him well in his future endeavors,” said Peter Scott.
There is no change to the Company’s previously issued 2025 Normalized FFO guidance, which was increased as part of reported third quarter 2025 financial results.
Healthcare Realty Trust Incorporated (NYSE: HR) is the largest, pure-play owner, operator and developer of medical outpatient buildings in the United States. Additional information regarding the Company can be found at www.healthcarerealty.com .
Investor Contact:
Ron Hubbard
Vice President, Investor Relations
P: 615.269.8290
Forward-Looking Statements
This press release contains certain forward-looking statements with respect to the Company. Forward-looking statements are statements that are not descriptions of historical facts and include statements regarding management’s intentions, beliefs, expectations, plans or predictions of the future, within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Because such statements include risks, uncertainties and contingencies, actual results may differ materially and in adverse ways from those expressed or implied by such forward-looking statements. Additional information concerning the Company and its business, including additional factors that could materially and adversely affect the Company’s financial results, include, without limitation, the risks described under Part I, Item 1A - Risk Factors, in the Company’s 2024 Annual Report on Form 10-K and in its other filings with the SEC.